cust.co / Companies / National Research (NRC)

National Research NRR

Net Revenue Retention history for National Research (NRC) - Healthcare SaaS, Public stage. Sourced from SEC filings and earnings releases.

Latest NRR · FY2025-Q4
101.0%
All-time peak
105.0%
FY-2022
All-time low
101.0%
FY-2023
Disclosures tracked
6
since FY-2022
QoQ ▼ 2.0pp
YoY ▼ 3.0pp

NRR vs GRR over time

88%93%98%102%107% FY-2022FY2022-Q4FY-2023FY2023-Q4FY2024-Q4FY2025-Q4 Retention NRR (incl. expansion) GRR (excl. expansion) NRR — FY-2022: 105% NRR — FY2022-Q4: 104% NRR — FY-2023: 101% NRR — FY2023-Q4: 101% NRR — FY2024-Q4: 103% NRR — FY2025-Q4: 101% GRR — FY-2022: 93% GRR — FY2022-Q4: 91% GRR — FY-2023: 90% GRR — FY2023-Q4: 90% GRR — FY2024-Q4: 93% GRR — FY2025-Q4: 92%

Gross Retention excludes expansion - it shows pure churn / contraction loss. The gap between NRR and GRR is the expansion lift.

Peak NRR of 105.0% in FY-2022. Latest is 101.0% - that's -4.0pp from peak.

National Research is below the Healthcare SaaS Public median by -7.5pp (cell median: 109%)

What the data shows

National Research (NRC) is a healthcare saas company at the public stage. As of its most recent disclosure (FY2025-Q4), National Research reported a Net Revenue Retention rate of 101.0% - a mid-pack result for B2B SaaS at this segment.

National Research's NRR peaked at 105.0% in FY-2022, 4pp above today's level. The most recent quarter lost 2.0pp QoQ.

Within its peer set (healthcare saas companies at public stage in the $100k-$500k acv band), National Research's NRR is below the cell median of 109%. Compare against the full peer cell aggregate for distribution and top performers.

Customer mix

Total customers
Over $100K ARR
Over $1M ARR
US revenue mix
Top-10 concentration
Average ACV

Commercial structure

Contract shape and forward-booked revenue.

Multi-year contracts
Avg contract length
RPO (total)
$105M
2025-12-31
cRPO (next 12mo)
$82M
2025-12-31
New customers added
Subscription rev mix
95%
2025-12-31

Customer experience

Health scores, usage, and time-to-value when disclosed.

NPS
68
2025-12-31
CSAT
Active users
Products per customer
Time to value

Scale & headcount

Revenue, ARR, and team-size denominators for the productivity ratios.

Revenue (period)
$38M
2025-12-31
Total ARR
$158M
2025-12-31
ARR growth (YoY)
4%
2025-12-31
AE headcount
Total employees

RPO duration breakdown

Forward-booked revenue by maturity. Renewal pipeline visibility.

Next 12 months
$82M
2025-12-31
13–24 months
Over 24 months
Total RPO
$105M
2025-12-31

The post-sales motion

Pricing model
subscription
Renewal cadence
annual
CS team size
Customers per CSM

Education programs: hosted customer conferences

Derived signals

Computed from the data above. Shows where value comes from and where leakage hides.

Expansion contribution
9.0pp
NRR − GRR
GRR drag
8.0%
churn + contraction

What National Research is doing

Named CS initiatives across recent disclosures (newest first).

What they're working through

Challenges acknowledged by management. Useful peer signals — your team is probably not alone.

What execs say about post-sales

Curated quotes about customer outcomes, retention, renewals.

"Our commitment to Human Understanding® helps leading healthcare systems improve their operations through understanding each person they serve not as point-in-time insights, but as an ongoing relationship."
Management Discussion, MD&A (Item 2. Management’s Discussion and Analysis)

Competitive dynamics

Get notified when National Research next discloses

One email when NRC's next quarterly NRR figure is verified. No spam, work email only, unsubscribe anytime.

We send roughly 1 email per quarter, only when verified data lands.

Embed this chart

Free to embed on your blog or board deck. Includes a small backlink to cust.co.

<iframe src="https://cust.co/companies/nrc/embed/" width="600" height="400" frameborder="0"></iframe>

Or grab the data: JSON API

Every disclosure

Period NRR GRR Source type Filing
FY2025-Q4 101.0% 92.0% presentation-pdf source ↗
FY2024-Q4 103.0% 93.0% presentation-pdf source ↗
FY2023-Q4 101.0% 90.0% presentation-pdf source ↗
FY-2023 101.0% 90.0% presentation-pdf source ↗
FY2022-Q4 104.0% 91.0% presentation-pdf source ↗
FY-2022 105.0% 93.0% presentation-pdf source ↗
Last verified disclosure: 2025-12-31 · Report an inaccuracy → · How we verify →

How does your NRR compare to National Research's?

Free calculator. We email a shareable percentile badge.